The Use of Radiolabeled Low Density Lipoprotein for Evaluating Atherosclerosis: Present Status and Future Promise
Emerging noninvasive techniques such as magnetic resonance imaging, vascular ultrasound, and synchrotron angiography promise in vivo detection and analysis of atherosclerosis in ways that could only be imagined a decade ago. Conventional invasive arteriography, verified whenever possible by dissection and lesion component morphometry, remains the gold standard for revealing atheroma location and lesion-associated stenosis. Yet the newer modalities are acquiring the power and the resolution that may permit accurate assessment of plaque size and shape; of spatial disposition of lipid, mineral, and tissue components within a plaque; and of structural distortions and adaptations in the artery wall adjacent to an atherosclerotic lesion.
KeywordsAtherosclerotic Lesion Nuclear Imaging Gamma Camera Image Fractional Catabolic Rate Radionuclide Accumulation
Unable to display preview. Download preview PDF.
- 2.S. M. Moerlein, K. B. Dalai, S. N. Ebbe, Y. Yano, and T. F. Budinger, Residualizing and non-residualizing analogues of low-density lipoprotein as iodine-123 radiopharmaceuticals for imaging LDL catabolism, Nucl. Med. Biol. 15:141 (1988).Google Scholar
- 4.R. Hay, R. Fleming, V. Stark, K. Lathrop, and P. Harper, Biodistribution of low density lipoprotein in normal and hyperlipemic animals. Cor Notes 3:5 (1988).Google Scholar
- 5.J. W. Ryan, P. V. Harper, R. V. Hay, K. A. Williams, K. A. Lathrop, V. J. Stark, and R. M. Fleming, Human biodistribution of 1–123 and Tc-99m labeled LDL, J. Nucl. Med. 29:803 (1988).Google Scholar
- 6.J. W. Ryan, P. V. Harper, R. V. Hay, K. A. Williams, K. A. Lathrop, V. J. Stark, and R. M. Fleming, Comparison of radiolabeled LDLs for detection of atherosclerotic plaques in humans, Eur. Heart J. 9 (Suppl.l):158 (1988).Google Scholar
- 7.R. V. Hay, R. M. Fleming, J. W. Ryan, K. A. Williams, V. J. Stark, K. A. Lathrop, and P. V. Harper, Nuclear imaging analysis of human low density lipoprotein biodistribution in rabbits and monkeys, J. Nucl. Med. in press (1991).Google Scholar
- 9.R. V. Hay, J. W. Ryan, K. A. Williams, R. W. Atcher, M. W. Brechbiel, O. A. Gansow, V. J. Stark, R. M. Fleming, R. J. Donati, K. A. Lathrop, and P. V. Harper, Indium-111-[SCN-Bz-DTPA]-low density lipoprotein: A new agent for extended nuclear imaging and detection of atheromata, in: “Cardiovascular Science & Technology: Basic and Applied, I,” J. Norman, ed. Oxymoron Press, Louisville (1989).Google Scholar
- 10.J. M. Esteban, J. Schlom, O. A. Gansow, R. W. Atcher, M. W. Brechbiel, D. E. Simpson, and D. Colcher, New method for the chelation of Indium-Ill to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts, J. Nucl. Med. 28:861 (1987).PubMedGoogle Scholar
- 12.M. D. Gross, R. W. S. Skinner, S. W. Schwendner, L. E. DeForge, R. E. Counsell, and R. S. Newton, Indium-111-DTPA-low density lipoprotein (LDL) imaging of LDL-receptor activity, J. Nucl. Med. 30:768 (1989).Google Scholar
- 13.J. M. Nicolas, B. Leclef, H. Jardez, A. Keyeux, J. A. Melin, and A. Trouet, Imaging atherosclerotic lesions with In-Ill-labelled low density lipoproteins, J. Nucl. Med. 30:788 (1989).Google Scholar
- 14.J. M. Rosen, S. P. Butler, H. N. Ginsberg, G. E. Meinken, T. S. T. Wang, S. C. Srivastava, and P. O. Alderson, Development of In-Ill labeled LDL for imaging atherosclerotic lesions, J. Nucl. Med. 30:787 (1989).Google Scholar
- 16.R. S. Lees, A. M. Lees, A. J. Fischman, and H. W. Strauss, External imaging of active atherosclerosis with 99mTc-LDL, in; “Pathobiology of the Human Atherosclerotic Plaque,” S. Glagov, W. P. Newman III, and S. A. Schaffer, eds., Springer-Verlag, New York (1990).Google Scholar